Bénéfices
| Q1 2024 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 3.890 | 4.780 | 0.8900 |
| Révision: | $2.84B | $2.64B | $40.00M |
| Q4 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 3.720 | 4.580 | 0.8600 |
| Révision: | $2.80B | $2.65B | $183.00M |
| Q3 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 2.580 | 4.290 | 1.7100 |
| Révision: | $2.69B | $2.55B | $84.00M |
| Q2 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 2.570 | 3.890 | 1.3200 |
| Révision: | $2.64B | $2.51B | $92.00M |
